- Home
- BVS vs KURA Comparison
BVS vs KURA Comparison
Compare BVS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- KURA
- Stock Information
- Founded
- BVS 2011
- KURA 2014
- Country
- BVS United States
- KURA United States
- Employees
- BVS N/A
- KURA N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BVS Health Care
- KURA Health Care
- Exchange
- BVS Nasdaq
- KURA Nasdaq
- Market Cap
- BVS 496.7M
- KURA 561.9M
- IPO Year
- BVS 2021
- KURA N/A
- Fundamental
- Price
- BVS $6.69
- KURA $5.71
- Analyst Decision
- BVS Strong Buy
- KURA Strong Buy
- Analyst Count
- BVS 4
- KURA 12
- Target Price
- BVS $15.00
- KURA $24.50
- AVG Volume (30 Days)
- BVS 407.6K
- KURA 1.3M
- Earning Date
- BVS 08-05-2025
- KURA 08-07-2025
- Dividend Yield
- BVS N/A
- KURA N/A
- EPS Growth
- BVS N/A
- KURA N/A
- EPS
- BVS N/A
- KURA N/A
- Revenue
- BVS $567,699,000.00
- KURA $67,991,000.00
- Revenue This Year
- BVS N/A
- KURA $109.86
- Revenue Next Year
- BVS $6.11
- KURA $107.90
- P/E Ratio
- BVS N/A
- KURA N/A
- Revenue Growth
- BVS 8.60
- KURA N/A
- 52 Week Low
- BVS $5.47
- KURA $5.41
- 52 Week High
- BVS $14.38
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- BVS 49.61
- KURA 39.74
- Support Level
- BVS $6.52
- KURA $5.73
- Resistance Level
- BVS $6.86
- KURA $5.88
- Average True Range (ATR)
- BVS 0.26
- KURA 0.28
- MACD
- BVS 0.04
- KURA -0.07
- Stochastic Oscillator
- BVS 54.65
- KURA 7.51
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.